Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Search for a novel diagnostic marker for liver cancer.

ABSTRACT: Search for a novel diagnostic marker for liver cancer.

PROVIDER: PRJNA481878 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Search for a novel diagnostic marker for liver cancer.

Project description:Search for a novel diagnostic marker for liver cancer.

| PRJNA668068 | ENA

Search for a novel diagnostic marker for liver cancer.

Project description:Analysis of the gene expression proﬁles of tumor and normal tissue samples from Hepatocellular carcinoma (HCC). Find potential secretory protein to serve as diagnostic marker for liver cancer.

2019-04-02 | GSE117361 | GEO

Search for a novel diagnostic marker for liver cancer.

Project description:Analysis of the circular RNA expression proﬁles of tumor and normal tissue samples from Hepatocellular carcinoma (HCC).Find potential circular RNA to serve as diagnostic marker for liver cancer.

2020-10-09 | GSE159220 | GEO

Novel Molecular Marker for Nociceptors

Project description:Novel Molecular Marker for Nociceptors

| PRJNA1416944 | ENA

CD271/p75NTR is a novel diagnostic marker, prognostic indicator and therapeutic target in SHH medulloblastoma

Project description:CD271/p75NTR is a novel diagnostic marker, prognostic indicator and therapeutic target in SHH medulloblastoma

| PRJNA421151 | ENA

ECRG4 as a novel diagnostic plasma marker detected in the early phase of Alzheimer’s disease

Project description:ECRG4 as a novel diagnostic plasma marker detected in the early phase of Alzheimer’s disease

| PRJNA1276560 | ENA

CD271/p75NTR is a novel diagnostic marker, prognostic indicator and therapeutic target in SHH medulloblastoma

Project description:The extensive heterogeneity both between and within the medulloblastoma (MB) subgroups underscores a critical need for variant-specific biomarkers and therapeutic strategies. We previously identified a role for the CD271/p75 neurotrophin receptor (p75NTR) in regulating stem/progenitor cells in the SHH MB subgroup. Here, we demonstrate the utility of CD271 as a novel diagnostic and prognostic marker for SHH MB using immunohistochemical analysis as well as transcriptome data across 763 primary tumors. Characterization of CD271+ and CD271- cells by RNA sequencing revealed that these two subpopulations are molecularly distinct, co-existing cellular subsets both in vitro and in vivo. MAPK/ERK signaling is upregulated in the CD271+ population and inhibiting this pathway reduced CD271 levels, stem/progenitor cell proliferation and cell survival as well as cell migration in vitro. Importantly, the MEK inhibitor selumetinib extends survival and reduces CD271 levels in vivo. Our study demonstrates the clinical utility of CD271 as both a diagnostic and prognostic tool for SHH MB tumors and reveals a novel role for MEK inhibitors in targeting CD271+ SHH MB cells.

2019-12-31 | GSE107701 | GEO

Diagnostic marker for lung cancer through microarray analysis

2011-06-14 | GSE29927 | GEO

MiR-146a-5p and miR-191-5p as novel diagnostic marker candidates for ovarian clear cell carcinoma

Project description:MiR-146a-5p and miR-191-5p as novel diagnostic marker candidates for ovarian clear cell carcinoma

| PRJNA1000564 | ENA

Diagnostic marker for lung cancer through microarray analysis

Project description:Dr. Kate Olson's Lab is interested to expand these analysis to comparisons between human normal lung tissue and human lung tumor tissue. In hopes that this will help in finding a diagnostic marker for lung cancer. Since there will be more variability between these samples, we would like to get preliminary data on ten normal lung tissue and ten lung tumor tissues from the same patient. We have already analyzed 4 cell lines and we saw gene expression variability related to how metastatic the cell lines were. This has been written and submitted for publication. We would like to expand these analysis to comparisons between human normal lung tissue and human lung tumor tissue. We hope that this will help in finding a diagnostic marker for lung cancer. Since there will be more variability between these samples, we would like to get preliminary data on ten normal lung tissue and ten lung tumor tissues from the same patient. The samples were dissected by a pathologist prior to extraction to maximize the amount of normal tissue included in the tumor samples. RNA samples from non tumor and tumor lung cancer patients were received by Core E. The RNA was amplified, labeled, and hybridized to the GLYCOv3 microarrays.

2011-06-14 | E-GEOD-29927 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data